Request Sample Inquiry
Artificial Intelligence in Drug Discovery Market

Artificial Intelligence in Drug Discovery Market

Artificial Intelligence in Drug Discovery Market - Global Industry Assessment & Forecast

img
Healthcare
Number Of Pages # Pages:

175

Base Year:

2022

Date

Feb - 2022

Format:

PDF XLS PPT

Report Code:

VMR-1239

Segments Covered
  • By Application By Application Drug Optimization and Repurposing, Preclinical Testing, Others
  • By Therapeutic Look By Therapeutic Look Oncology, Neurodegenerative Diseases, Cardiovascular Disease, Metabolic Diseases, Infectious Disease, Others
  • By Region By Region North America, Latin America, Europe, Asia Pacific, Middle East & Africa
Snapshot
Base YearBase Year: 2022
Forecast YearsForecast Years: 2023 - 2030
Historical YearsHistorical Years: 2017 - 2021
Revenue 2022Revenue 2022: USD 885.32 Million
Revenue 2030Revenue 2030: USD 13988.71 Million
Revenue CAGRRevenue CAGR (2023 - 2030): 41.20%
Fastest Growing Region Fastest Growing Region (2023 - 2030) Asia Pacific
Largest Region Largest Region (2022): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst
  1. Executive Dashboard
    1. Strategic Imperatives
  2. Premium Insights
    1. Top 3 Trends to Watch
    2. Demand and Supply Trends
    3. Top 3 Strategies Followed by Major Players
    4. Top 3 Predictions by Vantage Market Research
    5. Top Investment Pockets
    6. Insights from Primary Respondents
  3. Global Artificial Intelligence in Drug Discovery Market - Segment Analysis
    1. Overview
    2. Global Artificial Intelligence in Drug Discovery Market, 2016 - 2028 (USD Million)
    3. Global Artificial Intelligence in Drug Discovery Market - by Application
      1. By Drug Optimization and Repurposing
      2. By Preclinical Testing
      3. By Others
    4. Global Artificial Intelligence in Drug Discovery Market - by Therapeutic Look
      1. By Oncology
      2. By Neurodegenerative Diseases
      3. By Cardiovascular Disease
      4. By Metabolic Diseases
      5. By Infectious Disease
      6. By Others
    5. Global Artificial Intelligence in Drug Discovery Market - by region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
    6. Market comparative analysis
  4. North America Artificial Intelligence in Drug Discovery Market - Segment Analysis
    1. Overview
    2. North America Artificial Intelligence in Drug Discovery Market, 2016 - 2028 (USD Million)
    3. North America Artificial Intelligence in Drug Discovery Market, by Application
      1. By Drug Optimization and Repurposing
      2. By Preclinical Testing
      3. By Others
    4. North America Artificial Intelligence in Drug Discovery Market, by Therapeutic Look
      1. By Oncology
      2. By Neurodegenerative Diseases
      3. By Cardiovascular Disease
      4. By Metabolic Diseases
      5. By Infectious Disease
      6. By Others
    5. North America Artificial Intelligence in Drug Discovery Market, by Country
      1. U.S.
        1. U.S. Artificial Intelligence in Drug Discovery Market, By Application
          1. By Drug Optimization and Repurposing
          2. By Preclinical Testing
          3. By Others
        2. U.S. Artificial Intelligence in Drug Discovery Market, By Therapeutic Look
          1. By Oncology
          2. By Neurodegenerative Diseases
          3. By Cardiovascular Disease
          4. By Metabolic Diseases
          5. By Infectious Disease
          6. By Others
      2. Canada
        1. Canada Artificial Intelligence in Drug Discovery Market, By Application
          1. By Drug Optimization and Repurposing
          2. By Preclinical Testing
          3. By Others
        2. Canada Artificial Intelligence in Drug Discovery Market, By Therapeutic Look
          1. By Oncology
          2. By Neurodegenerative Diseases
          3. By Cardiovascular Disease
          4. By Metabolic Diseases
          5. By Infectious Disease
          6. By Others
      3. Mexico
        1. Mexico Artificial Intelligence in Drug Discovery Market, By Application
          1. By Drug Optimization and Repurposing
          2. By Preclinical Testing
          3. By Others
        2. Mexico Artificial Intelligence in Drug Discovery Market, By Therapeutic Look
          1. By Oncology
          2. By Neurodegenerative Diseases
          3. By Cardiovascular Disease
          4. By Metabolic Diseases
          5. By Infectious Disease
          6. By Others
  5. Europe Artificial Intelligence in Drug Discovery Market - Segment Analysis
    1. Overview
    2. Europe Artificial Intelligence in Drug Discovery Market, 2016 - 2028 (USD Million)
    3. Europe Artificial Intelligence in Drug Discovery Market, by Application
      1. By Drug Optimization and Repurposing
      2. By Preclinical Testing
      3. By Others
    4. Europe Artificial Intelligence in Drug Discovery Market, by Therapeutic Look
      1. By Oncology
      2. By Neurodegenerative Diseases
      3. By Cardiovascular Disease
      4. By Metabolic Diseases
      5. By Infectious Disease
      6. By Others
    5. Europe Artificial Intelligence in Drug Discovery Market, by Country
      1. Germany
        1. Germany Artificial Intelligence in Drug Discovery Market, By Application
          1. By Drug Optimization and Repurposing
          2. By Preclinical Testing
          3. By Others
        2. Germany Artificial Intelligence in Drug Discovery Market, By Therapeutic Look
          1. By Oncology
          2. By Neurodegenerative Diseases
          3. By Cardiovascular Disease
          4. By Metabolic Diseases
          5. By Infectious Disease
          6. By Others
      2. UK
        1. UK Market, By Application
          1. By Drug Optimization and Repurposing
          2. By Preclinical Testing
          3. By Others
        2. UK Market, By Therapeutic Look
          1. By Oncology
          2. By Neurodegenerative Diseases
          3. By Cardiovascular Disease
          4. By Metabolic Diseases
          5. By Infectious Disease
          6. By Others
      3. France
        1. France Artificial Intelligence in Drug Discovery Market, By Application
          1. By Drug Optimization and Repurposing
          2. By Preclinical Testing
          3. By Others
        2. France Artificial Intelligence in Drug Discovery Market, By Therapeutic Look
          1. By Oncology
          2. By Neurodegenerative Diseases
          3. By Cardiovascular Disease
          4. By Metabolic Diseases
          5. By Infectious Disease
          6. By Others
      4. Spain
        1. Spain Artificial Intelligence in Drug Discovery Market, By Application
          1. By Drug Optimization and Repurposing
          2. By Preclinical Testing
          3. By Others
        2. Spain Artificial Intelligence in Drug Discovery Market, By Therapeutic Look
          1. By Oncology
          2. By Neurodegenerative Diseases
          3. By Cardiovascular Disease
          4. By Metabolic Diseases
          5. By Infectious Disease
          6. By Others
      5. Italy
        1. Italy Artificial Intelligence in Drug Discovery Market, By Application
          1. By Drug Optimization and Repurposing
          2. By Preclinical Testing
          3. By Others
        2. Italy Artificial Intelligence in Drug Discovery Market, By Therapeutic Look
          1. By Oncology
          2. By Neurodegenerative Diseases
          3. By Cardiovascular Disease
          4. By Metabolic Diseases
          5. By Infectious Disease
          6. By Others
      6. BENELUX
        1. BENELUX Artificial Intelligence in Drug Discovery Market, By Application
          1. By Drug Optimization and Repurposing
          2. By Preclinical Testing
          3. By Others
        2. BENELUX Artificial Intelligence in Drug Discovery Market, By Therapeutic Look
          1. By Oncology
          2. By Neurodegenerative Diseases
          3. By Cardiovascular Disease
          4. By Metabolic Diseases
          5. By Infectious Disease
          6. By Others
      7. Rest of Europe
        1. Rest Of Europe Artificial Intelligence in Drug Discovery Market, By Application
          1. By Drug Optimization and Repurposing
          2. By Preclinical Testing
          3. By Others
        2. Rest Of Europe Artificial Intelligence in Drug Discovery Market, By Therapeutic Look
          1. By Oncology
          2. By Neurodegenerative Diseases
          3. By Cardiovascular Disease
          4. By Metabolic Diseases
          5. By Infectious Disease
          6. By Others
  6. Asia Pacific Artificial Intelligence in Drug Discovery Market - Segment Analysis
    1. Overview
    2. Asia Pacific Artificial Intelligence in Drug Discovery Market, 2016 - 2028 (USD Million)
    3. Asia Pacific Artificial Intelligence in Drug Discovery Market, by Application
      1. By Drug Optimization and Repurposing
      2. By Preclinical Testing
      3. By Others
    4. Asia Pacific Artificial Intelligence in Drug Discovery Market, by Therapeutic Look
      1. By Oncology
      2. By Neurodegenerative Diseases
      3. By Cardiovascular Disease
      4. By Metabolic Diseases
      5. By Infectious Disease
      6. By Others
    5. Asia Pacific Artificial Intelligence in Drug Discovery Market, by Country
      1. China
        1. China Artificial Intelligence in Drug Discovery Market, By Application
          1. By Drug Optimization and Repurposing
          2. By Preclinical Testing
          3. By Others
        2. China Artificial Intelligence in Drug Discovery Market, By Therapeutic Look
          1. By Oncology
          2. By Neurodegenerative Diseases
          3. By Cardiovascular Disease
          4. By Metabolic Diseases
          5. By Infectious Disease
          6. By Others
      2. Japan
        1. Japan Artificial Intelligence in Drug Discovery Market, By Application
          1. By Drug Optimization and Repurposing
          2. By Preclinical Testing
          3. By Others
        2. Japan Artificial Intelligence in Drug Discovery Market, By Therapeutic Look
          1. By Oncology
          2. By Neurodegenerative Diseases
          3. By Cardiovascular Disease
          4. By Metabolic Diseases
          5. By Infectious Disease
          6. By Others
      3. India
        1. India Artificial Intelligence in Drug Discovery Market, By Application
          1. By Drug Optimization and Repurposing
          2. By Preclinical Testing
          3. By Others
        2. India Artificial Intelligence in Drug Discovery Market, By Therapeutic Look
          1. By Oncology
          2. By Neurodegenerative Diseases
          3. By Cardiovascular Disease
          4. By Metabolic Diseases
          5. By Infectious Disease
          6. By Others
      4. South Korea
        1. South Korea Artificial Intelligence in Drug Discovery Market, By Application
          1. By Drug Optimization and Repurposing
          2. By Preclinical Testing
          3. By Others
        2. South Korea Artificial Intelligence in Drug Discovery Market, By Therapeutic Look
          1. By Oncology
          2. By Neurodegenerative Diseases
          3. By Cardiovascular Disease
          4. By Metabolic Diseases
          5. By Infectious Disease
          6. By Others
      5. South East Asia
        1. South East Asia Artificial Intelligence in Drug Discovery Market, By Application
          1. By Drug Optimization and Repurposing
          2. By Preclinical Testing
          3. By Others
        2. South East Asia Artificial Intelligence in Drug Discovery Market, By Therapeutic Look
          1. By Oncology
          2. By Neurodegenerative Diseases
          3. By Cardiovascular Disease
          4. By Metabolic Diseases
          5. By Infectious Disease
          6. By Others
      6. Rest of Asia Pacific
        1. Rest of Asia Pacific Artificial Intelligence in Drug Discovery Market, By Application
          1. By Drug Optimization and Repurposing
          2. By Preclinical Testing
          3. By Others
        2. Rest of Asia Pacific Artificial Intelligence in Drug Discovery Market, By Therapeutic Look
          1. By Oncology
          2. By Neurodegenerative Diseases
          3. By Cardiovascular Disease
          4. By Metabolic Diseases
          5. By Infectious Disease
          6. By Others
  7. Latin America Artificial Intelligence in Drug Discovery Market - Segment Analysis
    1. Overview
    2. Latin America Artificial Intelligence in Drug Discovery Market, 2016 - 2028 (USD Million)
    3. Latin America Artificial Intelligence in Drug Discovery Market, by Application
      1. By Drug Optimization and Repurposing
      2. By Preclinical Testing
      3. By Others
    4. Latin America Artificial Intelligence in Drug Discovery Market, by Therapeutic Look
      1. By Oncology
      2. By Neurodegenerative Diseases
      3. By Cardiovascular Disease
      4. By Metabolic Diseases
      5. By Infectious Disease
      6. By Others
    5. Latin America Artificial Intelligence in Drug Discovery Market, by Country
      1. Brazil
        1. Brazil Artificial Intelligence in Drug Discovery Market, By Application
          1. By Drug Optimization and Repurposing
          2. By Preclinical Testing
          3. By Others
        2. Brazil Artificial Intelligence in Drug Discovery Market, By Therapeutic Look
          1. By Oncology
          2. By Neurodegenerative Diseases
          3. By Cardiovascular Disease
          4. By Metabolic Diseases
          5. By Infectious Disease
          6. By Others
      2. Argentina
        1. Argentina Artificial Intelligence in Drug Discovery Market, By Application
          1. By Drug Optimization and Repurposing
          2. By Preclinical Testing
          3. By Others
        2. Argentina Artificial Intelligence in Drug Discovery Market, By Therapeutic Look
          1. By Oncology
          2. By Neurodegenerative Diseases
          3. By Cardiovascular Disease
          4. By Metabolic Diseases
          5. By Infectious Disease
          6. By Others
      3. Rest of Latin America
        1. Rest of Latin America Artificial Intelligence in Drug Discovery Market, By Application
          1. By Drug Optimization and Repurposing
          2. By Preclinical Testing
          3. By Others
        2. Rest of Latin America Artificial Intelligence in Drug Discovery Market, By Therapeutic Look
          1. By Oncology
          2. By Neurodegenerative Diseases
          3. By Cardiovascular Disease
          4. By Metabolic Diseases
          5. By Infectious Disease
          6. By Others
  8. Middle East & Africa Artificial Intelligence in Drug Discovery Market - Segment Analysis
    1. Overview
    2. Middle East & Africa Artificial Intelligence in Drug Discovery Market, 2016 - 2028 (USD Million)
    3. Middle East & Africa Artificial Intelligence in Drug Discovery Market, by Application
      1. By Drug Optimization and Repurposing
      2. By Preclinical Testing
      3. By Others
    4. Middle East & Africa Artificial Intelligence in Drug Discovery Market, by Therapeutic Look
      1. By Oncology
      2. By Neurodegenerative Diseases
      3. By Cardiovascular Disease
      4. By Metabolic Diseases
      5. By Infectious Disease
      6. By Others
    5. Middle East & Africa Artificial Intelligence in Drug Discovery Market, by Country
      1. GCC Countries
        1. GCC Countries Artificial Intelligence in Drug Discovery Market, By Application
          1. By Drug Optimization and Repurposing
          2. By Preclinical Testing
          3. By Others
        2. GCC Countries Artificial Intelligence in Drug Discovery Market, By Therapeutic Look
          1. By Oncology
          2. By Neurodegenerative Diseases
          3. By Cardiovascular Disease
          4. By Metabolic Diseases
          5. By Infectious Disease
          6. By Others
      2. South Africa
        1. South Africa Artificial Intelligence in Drug Discovery Market, By Application
          1. By Drug Optimization and Repurposing
          2. By Preclinical Testing
          3. By Others
        2. South Africa Artificial Intelligence in Drug Discovery Market, By Therapeutic Look
          1. By Oncology
          2. By Neurodegenerative Diseases
          3. By Cardiovascular Disease
          4. By Metabolic Diseases
          5. By Infectious Disease
          6. By Others
      3. Rest of Middle East & Africa
        1. Rest of Middle East & Africa Artificial Intelligence in Drug Discovery Market, By Application
          1. By Drug Optimization and Repurposing
          2. By Preclinical Testing
          3. By Others
        2. Rest of Middle East & Africa Artificial Intelligence in Drug Discovery Market, By Therapeutic Look
          1. By Oncology
          2. By Neurodegenerative Diseases
          3. By Cardiovascular Disease
          4. By Metabolic Diseases
          5. By Infectious Disease
          6. By Others
  9. Key Market Dynamics
    1. Introduction
    2. Market Drivers
    3. Market Restraints
    4. Market Opportunities
    5. Porter's Five Forces Analysis
    6. PEST Analysis
    7. Regulatory Landscape
    8. Technology Landscape
    9. Regional Market Trends
  10. COVID 19 Impact Analysis
    1. Key strategies undertaken by companies to tackle COVID-19
    2. Short term dynamics
    3. Long term dynamics
  11. Marketing Stratagy Analysis
    1. Marketing Channel
    2. Direct Marketing
    3. Indirect Marketing
    4. Marketing Channel Development Trends
  12. Competative Landscape
    1. Competition Matrix - 2021
    2. Company Market Share Analysis - 2021
    3. Key Company Activities, 2018 - 2021
    4. Strategic Developments - Heat Map Analysis
    5. Company Offering Evaluation
    6. Company Regional Presence Evaluation
  13. Company Profiles
    1. IBM Corporation (US)
    2. Microsoft (US)
    3. and Google (US)
    4. NVIDIA Corporation (US)
    5. Atomwise Inc. (US)
    6. Deep Genomics (Canada)
    7. Cloud Pharmaceuticals (US)
    8. Insilico Medicine (US)
    9. BenevolentAI (UK)
    10. Exscientia (UK)
    11. Cyclica (Canada)
    12. BIOAGE (US)
    13. Numerate (US)
    14. NuMedii (US)
    15. Envisagenics (US)
    16. twoXAR (US)
    17. OWKIN Inc. (US)
    18. XtalPi (US)
    19. Verge Genomics (US)
    20. and BERG LLC (US)
  14. Key Primary Respondents - VERBATIM
  15. Discussion Guide
  16. Customization Offered
  17. Annexure
  18. List of Figures
  19. List of Tables
  20. List of Abbreviations
Vantage Market Research | 24-Feb-2022
Artificial Intelligence in Drug Discovery Market Anticipated to Reach USD 4,197.5 Million by 2028
FAQ
Frequently Asked Question

  • The global Artificial Intelligence in Drug Discovery valued at USD 885.32 Million in 2022 and is expected to reach USD 13988.71 Million in 2030 growing at a CAGR of 41.20%.

  • The prominent players in the market are IBM Corporation (US), Microsoft (US), and Google (US), NVIDIA Corporation (US), Atomwise, Inc. (US), Deep Genomics (Canada), Cloud Pharmaceuticals (US), Insilico Medicine (US), BenevolentAI (UK), Exscientia (UK), Cyclica (Canada), BIOAGE (US), Numerate (US), NuMedii (US), Envisagenics (US), twoXAR (US), OWKIN, Inc. (US), XtalPi (US), Verge Genomics (US), and BERG LLC (US).

  • The market is project to grow at a CAGR of 41.20% between 2023 and 2030.

  • The driving factors of the Artificial Intelligence in Drug Discovery include

    • Increasing Demand for Artificial Intelligence in Drug Discovery

  • North America was the leading regional segment of the Artificial Intelligence in Drug Discovery in 2022.

Related Reports
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies Privacy Policy